Status not kept up to date
Standard Surgery or Minimal-Access Surgery in Treating Patients With Bladder Cancer
NCT01196403 · Wales Cancer Trials Unit · Updated 1 April 2011
- What is being tested
- questionnaire administration; quality-of-life assessment; robot-assisted laparoscopic surgery; therapeutic conventional surgery; therapeutic laparoscopic surgery
- For
- Bladder Cancer
- Kind of study
- Tests a treatment or device on volunteers. Phase 2.
- Who can join
- Ages 18 years and older. About 92 people. The full rules are on the registry page.
- Where
- United Kingdom (4 sites)
- When
- Starts or started Jan 2009. Registered 8 Sept 2010.
- Results
- None posted yet.
In the researchers' words
RATIONALE: Minimal-access surgery uses a smaller opening in the body to remove the tumor than is used in standard surgery. It is not yet known whether minimal-access surgery to remove the bladder is more effective than standard surgery to remove the bladder in treating patients with bladder cancer. PURPOSE: This randomized phase II trial is studying standard surgery to see how well it works compared with minimal-access surgery in treating patients with bladder cancer.
Sites
- Addenbrooke's HospitalCambridge, England, United Kingdom
- Guy's HospitalLondon, England, United Kingdom
- University College of London HospitalsLondon, England, United Kingdom
- Wales Cancer Trials UnitCardiff, Wales, United Kingdom